Three POU factors of subclass V, Oct-25, Oct-60 and Oct-91 are expressed in Xenopus oocytes and early embryos. We here demonstrate that vegetal overexpression of Oct-25, Oct-60, Oct-91 or mammalian Oct-3/4 suppresses mesendoderm formation in Xenopus embryos. Oct-25 and Oct-60 are shown to inhibit activin/nodal and FGF signaling pathways. Loss of Oct-25 and Oct-60 function results in elevated transcription of mesendodermal marker genes and ectopic formation of endoderm in the equatorial region of gastrula stage embryos. Within the ectoderm, Oct-25 promotes neural fate by upregulating neuroectodermal genes, such as Xsox2, which prevent differentiation of neural progenitors into neurons. We also show that mouse Oct-3/4 and Xenopus Oct-25 or Oct-60 behave as functional homologues. We conclude that Xenopus Oct proteins are required to control the levels of embryonic signaling pathways, thereby ensuring the correct specification of germ layers.
Introduction
Transcription factors of the POU family play important roles in embryogenesis, pattern formation and cellular differentiation. They are characterized by the POU domain and a POU specific homeodomain. According to sequence conservations within these domains and the linker in between, they can be subdivided into several subclasses (Ryan and Rosenfeld, 1997) . Of special importance, the mammalian transcription factor Oct-3/4, a member of subclass V, is required for self-renewal of embryonic stem (ES) cells and maintenance of pluripotency (Nichols et al., 1998) . The level of Oct-3/4 expression is essential for ES cell differentiation (Niwa et al., 2000; Hay et al., 2004) . Within the embryo, loss of Oct-3/4 leads to a failure of blastocyst cells to differentiate into different lineages. Instead, the cells become restricted to extraembryonic trophoectoderm (Nichols et al., 1998) . In Xenopus, three POU factors belonging to subclass V, Oct-60, Oct-25 and Oct-91 are expressed during oogenesis and early embryogenesis (Hinkley et al., 1992; Whitfield et al., 1993 Whitfield et al., , 1995 . Oct-60 is transcribed during oogenesis and transcripts are degraded by the early gastrula stage. Oct-25 is expressed from late oocyte to early neurula stage showing a maximum of zygotic transcripts during the early gastrula stage. Oct-91 is activated at early gastrula stage and peaks at late gastrulation. Transcripts of all three genes are highly enriched within the animal half of developing embryos. Functionally, Oct-25 overexpression leads to a lack of differentiation of neuroectoderm and mesoderm derived tissues (Cao et al., 2004) . This observation is consistent with an evolutionary conserved role of POU-V factors in the maintenance of an undifferentiated cell state.
In the present work, we have analysed by gain of function and by loss of function experiments the phenotypes of the three Xenopus POU-V factors and their role in ectodermal, mesodermal and endodermal marker gene expression. We made use of the animal cap assay, in which still undifferentiated presumptive ectodermal cells of the animal cap can be programmed by certain growth factors to differentiate to mesodermal and/or endodermal tissues. The classical factors that have been used in this assay are FGF and activin A (Slack et al., 1987; Asashima et al., 1990; Smith et al., 1990) . FGF acts as a competence factor for mesoderm induction or maintenance (Kimelman et al., 1988; Harland and Gerhart, 1997; LaBonne and Whitman, 1997) . Also, FGFs are potent neural inducers and posteriorize the neuroectoderm (Cox and Hemmati-Brivanlou, 1995; Lamb and Harland, 1995; Isaacs et al., 1998) . Activin A, a member of the transforming growth factor b (TGF-b) superfamily (Asashima et al., 1990; Smith et al., 1990) , is a dose-dependent inducer of mesoderm and endoderm (Ariizumi et al., 1991; Green and Smith, 1990; Gurdon et al., 1994) . However, the inducing activity of activin A is verified within the embryo by nodal, another member of the TGF-b superfamily (Agius et al., 2000) . Like activin A, nodal triggers a signaling pathway that plays critical roles in the formation of mesoderm and endoderm (combined as mesendoderm hereafter). Disruption of nodal signaling in vertebrates, such as mouse and fish, results in reduced formation of mesendoderm and consequently failure in body axis establishment. In Xenopus, six nodal related genes, Xnr1-6, are expressed from blastula through gastrulation (De Robertis and Kuroda, 2004) . With the exception of Xnr3, which is an aberrant member of nodal related proteins because of its role in neural induction, all other five are fundamental in mesendoderm formation. Ectopic expression of Xnrs induces ectopic mesendoderm formation. By contrast, inhibition of Xnrs by dominant-negative constructs or inhibitors such as Cerberus causes defects in mesendoderm formation. Downstream of the receptors for the ligands of the TGFb superfamily, the intracellular signal transducers, Smads, are acting. The Smad2/4 complex mediates the activation by the activin/nodal signal to the nucleus and regulates mesodermal and endodermal genes, like goosecoid, Xlim, Xnr1 and Mixer (Whitman, 2001) .
In the present study, we have found that Oct-25 and Oct-60 repress mesendoderm formation by blocking the activities of activin A and Xnrs. Both in the animal cap as well as in complete embryos, Xenopus POU-V factors antagonize activin/nodal signaling. Oct-25 in ectoderm promotes a neural fate by upregulating early neuroectodermal genes but suppresses terminal differentiation of neurons. We conclude that POU-V factors are essential to control the specification of germ layers in Xenopus embryos. Finally, we demonstrate that the knockdown phenotype of Xenopus POU-V factors can be rescued by mammalian Oct-3/4 indicating the functional relationship between these orthologous genes. or mouse Oct-3/4 RNAs in vegetal cells blocks formation of mesendoderm To examine how Xenopus Oct factors influence the formation of mesendoderm and whether they behave similarly to mouse Oct-3/4 (mOct-3/4), we have injected Oct-25, Oct-60, Oct-91 or mOct-3/4 RNA into four vegetal blastomeres at 8-cell stage. Whereas uninjected control embryos undergo normal gastrulation (Fig. 1A) , 100% of embryos injected with 400 pg of Oct-25 ( Fig. 1B ; n = 33) or 400 pg of Oct-60 ( Fig. 1C ; n = 41), 74% of embryos injected with 800 pg of Oct-91 ( Fig. 1D ; n = 39), and 70% of embryos injected with 400 pg of mOct-3/4 ( Fig. 1E ; n = 37) show no blastopore formation. These data suggest that Oct-25, Oct-60, Oct-91 and mOct-3/4 cause a developmental arrest. We then examined mesoderm and endoderm formation in the injected embryos by analyzing expression of the panmesodermal gene Xbra and endodermal gene Xsox17a at stage 11. Whole mount in situ hybridizations show the wild type patterns for Xbra and Xsox17a in control embryos ( Fig. 1F and K) , while in embryos injected with Oct-25 ( Fig. 1G and L) , Oct-60 ( Fig. 1H and M) , Oct-91 ( Fig. 1I and N) or mOct-3/4 RNA ( Fig. 1J and O), Xbra and Xsox17a are severely diminished, revealing that these Oct proteins repress both mesoderm and endoderm formation. We further examined the expression of a set of genes that are indicative of mesendoderm formation. Embryos were injected with 400 pg of Oct-25, Oct-60 or 600 pg of mOct-3/4 RNA into four vegetal blastomeres at 8-cell stage, collected at stage 10 and subjected to real-time RT-PCR. As shown in Fig. 1P , pan-mesodermal, ventral mesodermal and dorsal mesodermal marker genes, Xbra, Xwnt8, chordin, and goosecoid, are downregulated in injected embryos. Moreover, genes that are involved in mesoderm formation, like derriere, FGF3 and FGF8, are also repressed. Additionally, two genes that are involved in endoderm formation, Mixer and Xsox17a, are dramatically inhibited. In summary, overexpression of either Oct-25, Oct-60, Oct-91 or mOct-3/4 inhibits mesendoderm formation during Xenopus embryonic development.
Results

Overexpression of
Oct-25 promotes formation of neuroectoderm
We next have tested how ectoderm responds to overexpression of Oct-25. Four hundred picograms of Oct-25 RNA was injected close to the animal pole of all blastomeres at 4-cell stage. Animal caps were excised at stage 8.5 and cultured till control sibling embryos had reached stage 10. Expression of ectodermal genes was analyzed. We observed that the neuroectodermal genes Xsox2, Xsox3, Geminin and Zic1 are upregulated (Fig. 2) . Therefore, the animal cap assay suggests that Oct-25 promotes neural fate in ectoderm. It is known that Sox2, Sox3, Geminin and Zic1 promote neural differentiation and inhibit neuronal differentiation in Xenopus or other vertebrates (Kishi et al., 2000; Graham et al., 2003; Bylund et al., 2003; Aruga et al., 2002; Mizuseki et al., 1998; Seo et al., 2005) . In line with this, we observed no expression of the differentiated primary neuron specific N-tubulin gene in caps at stage 26 (data not shown). This finding is congruent with the roles of these neuroectodermal genes in preventing neural progenitor cells to differentiate into neurons.
Oct-25 overexpression inhibits the activities of activin A and bFGF in animal caps
Activins and FGFs are expressed maternally during Xenopus embryonic development (Kimelman et al., 1988; Asashima et al., 1991) and have been implicated in germ layer formation and tissue differentiation (Gurdon et al., 1994; Bottcher and Niehrs, 2005) . We therefore have tested, whether Oct-25 or Oct-60 overexpression has any influence on the activity of activin A or bFGF. First, animal caps were excised at stage 8.5 from uninjected embryos or from embryos injected with 600 pg Oct-25 or Oct-60 RNA, and treated with bFGF. Naïve caps without injection and treatment, which develop into atypical epidermis, were used as negative control (Fig. 3A) . The morphology of caps injected with 600 pg of Oct-25 (Fig. 3B) or Oct-60 RNA (Fig. 3C ) is similar to that of naïve caps. Uninjected caps treated with 500 ng/ml bFGF show mild elongation due to formation of mesoderm (Fig. 3D ). Caps injected with Oct-25 or Oct-60 RNA do not elongate at all (Fig. 3E and F) , suggesting that Oct-25 and Oct-60 can alter the inducing effect of bFGF. Secondly, we performed activin A treatment with uninjected caps or caps injected with 600 pg of Oct-25 or Oct-60 RNA. Uninjected caps treated with 10 ng/ml of activin A show characteristic elongation because of mesoderm formation (Fig. 3G ). In contrast, caps injected with Oct-25 or Oct-60 RNA and treated with activin A do not elongate at all (Fig. 3H and I) , suggesting that Oct-25 and Oct-60 inhibit the activity of activin A.
Real-time RT-PCR confirms that Oct-25 and Oct-60 inhibit the inducing activity of bFGF or activin A. Without bFGF or activin A treatment, there is no significant induction of mesodermal or endodermal gene expression in uninjected caps or caps injected with Oct-25 or Oct-60 RNA ( Fig. 3J and K). bFGF treatment induces in uninjected caps at stage 20 strong activation of trunk mesodermal genes, XMyoD and a-actin, as well as of the posterior neural marker gene, XhoxB9 (Fig. 3J ). The activation is dramatically repressed in caps from Oct-25 or Oct-60 injected embryos, confirming the inhibitory effect of Oct-25 or Oct-60 on the activity of bFGF (Fig. 3J) . Loss of mesoderm response by bFGF had also been reported for Oct-91 overexpression (Henig et al., 1998) . Activin A induces strong expression of dorsal or trunk mesodermal genes, Xnot, a-actin and XMyoD, as well as the endodermal gene Endodermin (Edd) (Fig. 3K ). In contrast, in caps injected with Oct-25 or Oct-60 RNA and treated with activin A, expression of these genes is severely repressed (Fig. 3K ). Taken together, we conclude that Oct-25 or Oct-60 can inhibit both the activities of activin A and bFGF in animal caps.
Oct-25 inhibits the activities of Xnrs in embryos
The nodal signaling pathway plays a critical role in mesendoderm formation. We therefore have asked whether Oct-25 could also inhibit the activity of nodal signaling, when nodals in the embryo are provided by overexpression. While uninjected control embryos show normal development ( Fig. 4A) , injection of 10 pg Xnr2 (Fig. 4B) , Xnr4 (Fig. 4D ) or Xnr5 RNA (Fig. 4F ) into the two ventral-vegetal blastomeres at 8-cell stage results in partial secondary axis formation in 92% (n = 36), 83% (n = 36) and 100% (n = 31), respectively, which corresponds to previous reports (Jones et al., 1995; Joseph and Melton, 1997) . Co-injection of 300 pg Oct-25 RNA with Xnr2 RNA results in failure of secondary axis formation in 54% of embryos (n = 52) (Fig. 4C) . When 300 pg of Oct-25 RNA is injected together with Xnr4 RNA, the secondary axis formation is inhibited in 64% of embryos (n = 44) (Fig. 4E) . But the rescued embryos reveal a truncated posterior structure. Co-injection of 300 pg Oct-25 RNA blocks the dorsalization effect of Xnr5 (Fig. 4F ) and results in almost normal development in 79% of embryos (n = 56) (Fig. 4G) . In summary, these results demonstrate that Oct-25 inhibits the activities of Xnrs in embryos.
Functional knockdown of Oct-25 and Oct-60 causes expansion of mesendoderm formation
We next have analyzed the effects of functional knockdown of endogenous Oct-25 and Oct-60 in the embryo by using antisense morpholino oligonucleotides (MO). As functional knockdown with MO in a previous study was not effective (Cao et al., 2004) , a new MO (Oct25MO) was designed to knockdown both pseudo-allelic versions of Xenopus Oct-25 (GenBank Accession Nos. AJ699165 and BC079821). Two MOs (Oct60MOa1 and Oct60MOb1) were designed to knockdown the two pseudo-allelic versions of Oct-60 (Accession Nos. X86377 and CA972414), separately. Before knockdown analysis, we examined the efficiency of MOs to interfere with in vivo protein expression. Immunoblotting shows that Oct25MO can efficiently block endogenous Oct-25 protein expression (Fig. 5A ) and Oct60MOa1 can block Oct-60MT fusion protein translation (Fig. 5B) . Because the other pseudo-allelic sequence of Oct-60 is only known by EST (Accession No. CA972414) and the complete cDNA is not yet available, the effectiveness of Oct60MOb1 on translation was not examined. Instead, we used a mix (Oct60MOs) composed of equal quantities of the two MOs in subsequent experiments.
Twenty nanograms of Oct25MO, 50 ng of Oct60MOs, or a mixture of 15 ng of Oct25MO and 40 ng of Oct60MOs was injected radially into all blastomeres at 4-cell stage. For control, embryos were injected with 50 ng of ctrlMO. Embryos injected with ctrlMO show normal blastopore formation and complete closure of the blastopore at the end of gastrulation (Fig. 5C ). 100% of embryos injected with Oct25MO ( Fig. 5D ; n = 41), 95% of embryos injected with Oct60MOs ( Fig. 5E ; n = 39), or 100% of embryos injected with Oct25MO and Oct60MOs ( Fig. 5F ; n = 43) show formation of a blastopore, which remains wide open and does not close at the end of gastrulation.
Because overexpression of Oct-25 or Oct-60 in embryos blocks formation of mesendoderm (Fig. 1) , we would expect an increase in mesendoderm in knockdown embryos. The embryos injected with MOs were subjected to whole mount in situ hybridization to examine the expression of Xbra and Xsox17a (Fig. 5G-J) . While Xbra and Xsox17a are expressed in correct pattern in embryos injected with ctrlMO ( Fig. 5G and I) , the vast majority of embryos injected with Oct MOs show an extension of the expression domains towards the equatorial region (72% in case of Xbra, 83% in case of Xsox17a) (Fig. 5H and J) . If viewed laterally or by corresponding sections, a rather broad expression domain is visible. These findings suggest that mesendoderm is excessively formed and shifted up towards the equatorial region, but we did never observe Xbra and Xsox17a expression within the animal cap. To confirm this observation, explants were excised at stage 9 from equatorial region, where mesoderm normally forms, cultured to stage 11, and subjected to analysis on expression of mesendodermal genes. Real-time RT-PCR reveals that mesodermal genes Xbra, Xwnt8 and goosecoid, and endodermal genes Xsox17a, Mixer, cerberus and Xhex, are all upregulated in the explants injected with MOs against Oct-25 and Oct-60 (Fig. 5K) . In summary, we conclude that mesoderm induction is enhanced and endoderm is ectopically induced in the equatorial region of gastrula stage embryos when Oct functions are depleted.
We additionally have examined the expression of neuroectodermal genes in animal caps in response to Oct functional knockdown. 20 ng of ctrlMO or Oct25MO was injected close to animal pole of all blastomeres at 4-cell stage. Animal caps were removed from the injected embryos at stage 8.5, cultured to stage 10.5, and subjected to real-time RT-PCR (Fig. 5L) . Contrary to Oct overexpression shown before (Fig. 2) , expression of Xsox2 is strongly downregulated, while expression of other genes, Xsox3, Zic1 and Geminin, is less significantly affected. The result suggests that Oct-25 is essential for the regulation of Xsox2 expression, which serves to maintain the identity of neural progenitors.
Functional knockdown of Oct-25 and Oct-60 can be rescued by mOct-3/4
A previous study has shown that Xenopus Oct-60 and Oct-25 are maternally expressed as is mammalian Oct-3/4 (Hinkley et al., 1992) . Moreover, overexpression of these Oct factors in Xenopus embryos causes similar phenotypes. We therefore have asked if Oct-25 or Oct-60 knockdown phenotype can be rescued by Oct-25, Oct-60 or mOct-3/4.
During tailbud stage, embryos injected with ctrlMO develop normally (Fig. 6A) . In contrast, those injected with Oct25MO or Oct60MOs show similarly severe developmental defects in body axis formation, head structures and neural fold closure ( Fig. 6B and C) . However, the anterior part of embryos is still discernible and somewhat exaggerated. Injection of a combination of these MOs generates a seemingly enhanced phenotype without any axial characteristics (Fig. 6D) .
Defects in 75% of embryos (n = 40) injected with Oct25MO can be rescued to nearly normal embryos by coinjection of 400 pg Oct-25 RNA (Fig. 6E) , and 66% of embryos (n = 38) injected with Oct60MOs can be rescued also to nearly normal embryos by co-injection of 350 pg Oct-60 RNA (Fig. 6F) . We conclude that the observed phenotypes are specific.
Co-injection of 200 pg Oct-25 RNA with Oct60MOs (Fig. 6G) or 200 pg Oct-60 RNA with Oct25MO (Fig. 6H ) rescues 74% (n = 35) or 82% (n = 45), respectively, of embryos in forming a body axis. These embryos exhibit normal neural fold closure as indicated by formation of dorsal fin, head and tail structures. Similarly, 300 pg mOct-3/4 reveals a rescuing effect on Oct25MO in 90% of embryos ( Fig. 6I ; n = 21) and 200 pg shows rescuing effect on Oct60MOs in 78% of embryos ( Fig. 6J ; n = 41). The rescuing effect demonstrates again that mOct-3/4 shares common functions with Xenopus maternal Oct factors during early embryogenesis.
Discussion
Oct-25 and Oct-60 maintain mesendodermal germ layer identity and promote neuroectoderm formation
Overexpression of Oct-25, Oct-60 or Oct-91 in the vegetal part of embryos causes a lack of blastopore formation. Resulting embryos do not undergo normal gastrulation. The observed phenotype already suggests that the mesodermal and endodermal germ layers are not properly formed. This is supported by the findings that expression of Xbra and Xsox17a is blocked. Real-time RT-PCR analyses show that marker genes for dorsal mesoderm, ventral mesoderm and endoderm are repressed. Congruent with this observation, expression of all genes that are indicative for mesendoderm induction and patterning are also repressed. Therefore, overexpression of the Oct factors in the vegetal half of embryos represses mesendodermal germ layer formation. Vice versa, functional knockdown of Oct-25 and Oct-60 in the equatorial region result in an increased transcription of mesendodermal genes, like Xbra, Xwnt8, goosecoid, Xsox17a, Mixer, cerberus and Xhex. The consequence of elevated transcriptional levels of these genes in the equatorial part of embryos is an increase of mesoderm formation and ectopic formation of endoderm. Therefore, insufficient or excessive levels of Oct proteins in embryos will be catastrophic for formation of mesendoderm. Enhanced transcription of endoderm-associated genes had been found as common feature of Oct-3/4 knockdown in both mouse and human ES cells (Hay et al., 2004; Chew et al., 2005) . However, zebrafish maternal-zygotic spg (pou2/Oct4) mutant embryos suggest that mutant cells develop into mesoderm at the expense of endoderm (Lunde et al., 2004; Reim et al., 2004) , although the mutant phenotype resembles the knockdown in Xenopus. The discrepancy is probably due to some differences in early induction signals between the two species. It will be interesting to investigate the effects of microinjection of zebrafish pou2 into Xenopus embryos.
When overexpressed in animal caps, Oct-25 upregulates neuroectodermal genes, such as Xsox2, Xsox3, Geminin and Zic1 at stage 10. Conversely, Oct-25 knockdown in animal caps significantly represses the expression of Xsox2, while the other neuroectodermal genes are only slightly affected. Therefore, Oct-25 is essential at least for the expression of Xsox2. The correlation between Oct-25 and Xsox2 is reminiscent of mutual upregulation of Oct-3/4 and Sox2 in mammalian ES cells (Chew et al., 2005) . Sox2 is required for neural differentiation, but counteracts neuronal differentiation via inhibition of proneural genes (Kishi et al., 2000; Graham et al., 2003; Bylund et al., 2003) . A lack of neuronal differentiation in animal caps overexpressing Oct-25 is reflected by the absence of N-tubulin expression, while in animal caps of Oct-25 knockdown embryos a low level of neuronal differentiation was observed (data not shown). In conclusion, Oct-25 is required for the maintenance of identity of neural progenitor cells via regulation of Xsox2.
Activin/nodal signaling is inhibited by Oct-25 and Oct-60
Oct-25 and Oct-60 exhibit also an inhibitory effect on the activities of activin/nodal and bFGF signaling pathways. Oct-25 overexpression overrides the activities of Xnrs, so that the dorsalizing effect of Xnrs is no more observed in Oct-25 co-injected embryos. Moreover, Oct-25 and Oct-60 block in animal caps mesendodermal tissue differentiation induced by activin A and mesodermal tissue differentiation induced by bFGF. Certain levels of activin and FGF signals exist in the animal region of early embryos (Cornell and Kimelman, 1994; LaBonne and Whitman, 1997) . Therefore, Oct-25 or Oct-60 may maintain ectodermal germ layer identity by blocking the activities of these signals in the animal region. It should be mentioned that a reverse rescuing experiment, by which we tried to revert the Oct-25 and Oct-60 phenotype by injection of Xnrs into the four vegetal blastomeres at 8-cell stage, was not successful (data not shown). This might be due to the fact that Oct factors suppress not only bFGF and activin/nodal signaling but also other primary inducing signals and signaling pathways. Therefore, the inhibition of mesendoderm formation by Xenopus Oct factors may not only be governed by suppression of bFGF and Xnr signaling but also by other pathways being essential for induction and patterning of mesendoderm. Based on the present findings, we propose the following model for germ layer specification in Xenopus embryos. While Oct-25 in the ectoderm promotes formation of neuroectoderm by upregulating neuroectodermal genes, Oct-25 and Oct-60 limit the functions of activin/nodal as well as of FGF signals and block excessive or ectopic formation of mesendoderm. The balance between these antagonistic activities, that means the temporally and spatially coordinated expression of inducing factors and POU factors, is a pre-requisite for the correct formation of primary germ layers.
Oct factors on one hand stimulate neuroectodermal genes, and on the other, inhibit genes for mesendoderm induction, meaning that they can both activate and repress gene expression. Probably, the temporal and spatial distribution of Oct proteins and their cofactors during embryonic development determines whether they have an activating or repressing function. This dual activity has also been observed for Oct-3/4 in mammalian ES cells (Pesce and Scholer, 2000) .
Functional conservation of POU-V factors
Three subclass V POU factors, Oct-25, Oct-60 and Oct-91, have been reported in Xenopus laevis (Hinkley et al., 1992; Whitfield et al., 1993 Whitfield et al., , 1995 . These three genes obviously arose by duplication of a common ancestor, since they are found to be clustered in Xenopus tropicalis (Ensembl v37, X. tropicalis, JGI 4; scaffold_886). Evolutionary divergence of gene control regions may account for the distinct temporal patterns (the temporal order of expression is reverse to their orientation within the cluster), but their combined temporal pattern corresponds to that of Oct-3/4 in mammals (Ovitt and Scholer, 1998 ). Functional analyses demonstrate that these Oct factors have functions in common in Xenopus embryos. Overexpression of Oct-25, Oct-60, or Oct-91 RNA generates the same phenotype as overexpression of mOct-3/4 RNA. In line with this observation, overexpressed Oct-25, Oct-60 or mOct-3/4 blocks transcription of a same set of mesendodermal genes. Moreover, Oct-25 as well as Oct-60 can block nodal or activin A activity. Finally, the fact that the Oct-25 or Oct-60 knockdown phenotype can be rescued by mOct-3/4 provides additional evidence that the mammalian Oct-3/4 factor and Xenopus Oct-25/Oct-60 factors are functional homologues. Oct-91 overexpression generates the same phenotype as the other Oct proteins. Whether it fully compensates for the function of Oct-25 or Oct-60, remains to be elucidated.
Experimental procedures
Embryos and explants
Embryos were obtained with in vitro fertilization and cultured in 0.1· MBSH (1· MBSH: 88 mM NaCl, 2.4 mM NaHCO 3 , 1 mM KCl, 0.82 mM MgSO 4 , 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 10 mM Hepes, pH 7.4). Animal cap explants were cut from uninjected or injected embryo at stage 8.5, equatorial explants were cut at stage 9, and cultured until control sibling embryos had reached the desired stages. For activin A, bFGF (R&D systems) treatment, caps were excised in the same way. After 3 h of treatment, they were then transferred to 0.5· MBSH for continuing culture to desired stages.
In vitro transcription of RNA and morpholino oligos
Coding region of Oct-60 (GenBank Accession No. X86377) was amplified with PCR from cDNA derived from stage 10 embryos, cloned to pCS2+ to obtain pCS2+Oct-60. Oct-60 cDNA that contains antisense morpholino oligo binding sequence was also amplified and fused to the N-terminus of myc-tags on pCS2+MT vector to make pCS2+Oct-60MT. pCS2+Oct-25, pCS+Oct-60, pCS2+Oct-60MT, pCS2+Oct-91, and pCS2+ mOct-3/4 were linearized with NotI, pSP64T-Xnr2 with SmaI, and pSP64TNE-Xnr4 was linearized with XbaI. These templates were transcribed with mMessage mMachine SP6 kit (Ambion). pNRRX-Xnr5 was linearized with XbaI, and transcribed with mMessage mMachine T7 kit (Ambion) to generate RNAs for microinjection. pBSK+Xbra was linearized with SalI, and pCS2+Xsox17a was linearized with ClaI. Both were transcribed with T7 RNA polymerase to make antisense probe for whole mount in situ hybridization.
Antisense morpholino oligonucleotide (Gene Tools) for Oct-25 functional knockdown (Oct25MO) was 5 0 -TTGGGAAGGGCTGTTGG CTGTACAT-3 0 . This morpholino fits to both pseudo-allelic versions of Xenopus Oct-25 (GenBank Accession Nos. AJ699165 and BC079821). To knockdown Oct-60, two antisense morpholino oligos, Oct60MOa1 with sequence 5 0 -TCCATCTCCAGCACTTGCTCAGGCC-3 0 and Oct60-MOb1 with sequence 5 0 -CCATTTCCAACACTTGGTCCCGCCC-3 0 , were designed to target two pseudo-allelic versions of Oct-60 (GenBank Accession Nos. X86377 and CA972414). A standard control oligo (ctrlMO) was 5 0 -CCTCTTACCTCAGTTACAATTTATA-3 0 .
Immunoblotting
A synthetic peptide with the sequence HKNDLFPQTVPH GMA at the C-terminus of Oct-25 was used to immunize a rabbit to generate an Oct-25 peptide antibody (Davids Biotechnologies). To test the efficiency of Oct60MOa1, Oct-60MT RNA was injected alone or together with Oct60MOa1 or with ctrlMO. Animal caps were removed for blotting. Thirty unfertilized eggs, embryos or animal caps were lyzed with 300 ll of lysis buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, 1% NP-40, protease inhibitor cocktail (Sigma)). Lysates were precipitated at 4°C, boiled in 1· Laemmli buffer, and subjected to Western blotting using standard procedure. Oct-25 peptide antibody was used at a dilution of 1:200, myc antibody was used at 1:2000 (Santa Cruz), followed by goat anti-rabbit IgG-peroxidase (Amersham) at 1:10000. Blots were then subjected to ECL (Amersham) and exposed to film.
Gene expression analysis using real-time RT-PCR
Total RNA was extracted from embryos or explants with QiaZol (Qiagen), followed by DNase I treatment and cleanup with RNeasy kit (Qiagen). First strand cDNA was synthesized from 2 lg of total RNA with RevertAidä First Strand cDNA Synthesis kit (Fermentas). LightCyclerä real-time RT-PCR (Roche) reactions were performed in a total volume of 20 ll containing 0.5 lM of each primer, 4 mM of MgCl 2 , 2 ll of Faststart SybrGreen master mix (Roche Molecular Biochemicals) and 2 ll of template cDNA at 1:10 dilution. Primers and cycling conditions are listed in Table 1 . All reactions were considered valid because no specific products were generated in negative controls with water alone or RT-instead of template cDNA. The amplification in samples with different primer pairs in the crossing point during loglinear phase, quantified by using LightCyclerä software version 1.0, was normalized to expression level of reference gene ODC (ornithine decarboxylase) included in each run. Finally, expression of each gene was calculated relative to uninjected control whole embryos, uninjected control caps or equatorial explants in which gene expression was considered as basal level. All experiments have been performed at least in triplicate. Data are averaged from three independent experiments and are presented in histograms with relative units.
Note added in proof
When this manuscript was still under review, another report on the role of Xenopus POU-V factors has been published (Morrison and Brickman, 2006) . While both studies reach similar conclusions in that Xenopus POU-V factors behave as functional homologues to mammalian Oct-3/4 and suppress germ layer formation, a discrepancy for the regulation of Xbra is noted. In contrast to this report, our results demonstrate that gain of function of Xenopus POU-V factors leads to a downregulation of Xbra and loss of function leads to an expansion of the expression domain towards the upper equatorial region. 
